Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:03 AM
Ignite Modification Date:
2025-12-25 @ 4:03 AM
NCT ID:
NCT05902702
Eligibility Criteria:
Inclusion Criteria:
* Children aged 0-12 months, whose parents give informed consent to participate, with symptoms of bronchiolitis including at least one of:
* Runny nose
* Dry and persistent cough
* Labored breathing (tachypnea, retractions, nasal flaring)
* Grunting
* Cyanosis or apnea
* Wheezing or crackles on auscultation
* O2 saturations below 92 %
* Difficulties feeding
Exclusion Criteria:
* Children with cystic fibrosis or other serious congenital lung diseases
* Children in whom treatment with short-acting beta-2 agonist is initiated (as this is delivered in nebulized isotonic saline).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Day
Maximum Age:
12 Months
Study:
NCT05902702
Study Brief:
Protocol Section:
NCT05902702